Esophageal Varices: Signs of High Bleeding Risk

2021 ◽  
Author(s):  
Yijie Yan ◽  
Yue Li ◽  
Chunlei Fan ◽  
Yuening Zhang ◽  
Shibin Zhang ◽  
...  

Abstract Background & aims: To develop and validate a novel machine learning-based radiomic model (RM) for diagnosing high bleeding risk esophageal varices (HREV) in cirrhosis. Methods: In training cohort, total 218 cirrhotic patients for mild esophageal varices (EV) and 240 for HREV RM were enrolled for training and internal validation. In external validation cohort, 159 and 340 cirrhotic patients were respectively used for mild EV and HREV RM validation. Interesting regions of liver, spleen, and esophagus were labeled on the portal venous-phase enhanced CT images. RM was assessed by area under the receiver operating characteristic curves (AUROC), sensitivity, specificity, calibration and decision curve analysis (DCA). Results: The AUROC of mild EV RM in training and internal validation was 0.943 and 0.732, sensitivity and specificity was 0.863, 0.773 and 0.763, 0.763. The AUROC, sensitivity and specificity was 0.654, 0.773 and 0.632 in external validation. Interestingly, the AUROC of HREV RM in training and internal validation was 0.983 and 0.834, sensitivity and specificity was 0.948, 0.916 and 0.977, 0.969. The AUROC, sensitivity and specificity was 0.736, 0.690 and 0.762 in external validation. Calibration and DCA indicated RM had good performance in clinical practice. Compared with Baveno VI and its expanded criteria, HREV RM had a higher accuracy and net reclassification improvement reached 49.0% and 32.8%. Conclusion: A novel non-invasive RM for diagnosing HREV in cirrhotic patients with highly accuracy was developed. However, this RM still needs to be validated by a multi-center large cohort.


2005 ◽  
Vol 42 (2) ◽  
pp. 72-76 ◽  
Author(s):  
Angelo Paulo Ferrari ◽  
Gustavo Andrade de Paulo ◽  
Claudia Maria Ferreira de Macedo ◽  
Isabela Araújo ◽  
Ermelindo Della Libera Jr

BACKGROUND: Endoscopic sclerotherapy is an absolute indication for treating esophageal varices. Re-bleeding is common during the treatment period, before all varices become eradicated. AIM: To compare two techniques of endoscopic esophageal varices eradication: sclerotherapy with absolute alcohol and banding ligation. PATIENTS AND METHOD: Forty-six patients with liver cirrhosis and esophageal varices were prospectively randomized into two treatment groups: endoscopic sclerotherapy with absolute alcohol and banding ligation. Patients were included if they had large varices with signs of high bleeding risk. Informed writing consent was obtained from every patient and the Ethics Committee of Federal University of São Paulo, SP, Brazil, approved the study. After eradication, all patients were followed up to 1 year to look for re-bleeding episodes and variceal recurrence. RESULTS: Both groups were similar except that male gender was more common in the sclerotherapy group. There was no statistical difference regarding variceal eradication (78.3% in sclerotherapy group vs 73.9% in the ligation group), recurrence (26.7% vs 42.9%, respectively) and death related to any cause (21.7% vs 13.9%). In the sclerotherapy group more sessions were need to obtain complete variceal eradication. In this group we did observe a high re-bleeding rate (34.8%) and more ulcers associated with retrosternal pain right after the procedure. There was no difference regarding overall morbidity and mortality. CONCLUSIONS: Banding ligation requires fewer sessions than sclerotherapy with absolute alcohol to eradicate esophageal varices. Both methods are equally efficient regarding variceal eradication and recurrence during a short follow-up period.


Open Heart ◽  
2021 ◽  
Vol 8 (2) ◽  
pp. e001761
Author(s):  
Mirvat Alasnag ◽  
Tara L Jones ◽  
Yasmin Hanfi ◽  
Nicola Ryan

Balancing ischaemic and bleeding risks in high-risk populations undergoing percutaneous coronary interventions has become an everyday dilemma for clinicians. It is particularly difficult to make decisions concerning combinations and duration of antiplatelet regimens in women given the poor representation of women in trials that have shaped current practice. Several contemporary landmark trials have recently been presented at the American College of Cardiology. The trials included the Harmonising Optimal Strategy for Treatment of coronary artery diseases-EXtended Antiplatelet Monotherapy, Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention and the TicAgrelor versus CLOpidogrel in Stabilised Patients With Acute Myocardial Infarction. In this article, we summarise the main findings of these trials and include the The Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk (LEADERS FREE) in search for evidence based best practices for women patients. Although some of these trials had prespecified a subanalysis of sex differences, women constituted only 17%–30% of participants making sex-specific analyses challenging. Data suggest that women benefit from de-escalation to both ticagrelor and clopidogrel monotherapy. However, given the increased bleeding risks observed in women further randomised controlled trials are necessary to determine the most appropriate combination and duration of dual antiplatelet therapy as well as maintenance single antiplatelet therapy.


2021 ◽  
Vol 77 (18) ◽  
pp. 899
Author(s):  
Stephan Windecker ◽  
Elvin Kedhi ◽  
Azeem Latib ◽  
David Kandzari ◽  
Ajay Kirtane ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document